共 216 条
[1]
Abulimiti M(2021)Combination intensity-modulated radiotherapy and sorafenib improves outcomes in hepatocellular carcinoma with portal vein tumor thrombosis J Oncol 2021 1-10
[2]
Li Z(2010)Stereotactic body radiation therapy: the report of AAPM Task Group 101: stereotactic body radiation therapy: the report of TG101 Med Phys 37 4078-4101
[3]
Wang H(2016)Phase 1 trial of sorafenib and stereotactic body radiation therapy for hepatocellular carcinoma Int J Radiat Oncol Biol Phys 94 580-587
[4]
Apiziaji P(2011)Management of hepatocellular carcinoma: an update Hepatology 53 1020-1022
[5]
Abulimiti Y(2016)Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma Gastroenterology 150 835-853
[6]
Tan Y(2013)Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma JCO 31 1631-1639
[7]
Benedict SH(2016)Management of hepatocellular carcinoma with portal vein tumor thrombosis: review and update at 2016 WJG 22 7289-1047
[8]
Yenice KM(2014)Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma Int J Radiat Oncol Biol Phys 88 1041-870
[9]
Followill D(2022)Clinical efficacy and safety of external radiotherapy combined with sorafenib in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis Ann Hepatol 27 100710-3793
[10]
Galvin JM(2004)Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated Int J Radiat Oncol Biol Phys 58 862-92